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Abstract
Background: Serine/arginine (SR) protein-specific kinases (SRPKs) are conserved in a wide range
of organisms, from humans to yeast. Studies showed that SRPKs can regulate the nuclear import
of SR proteins in cytoplasm, and regulate the sub-localization of SR proteins in the nucleus. But no
nuclear localization signal (NLS) of SRPKs was found. We isolated an SRPK-like protein PSRPK
(GenBank accession No. DQ140379) from Physarum polycephalum previously, and identified a NLS
of PSRPK in this study.
Results: We carried out a thorough molecular dissection of the different domains of the PSRPK
protein involved in its nuclear localization. By truncation of PSRPK protein, deletion of and single
amino acid substitution in a putative NLS and transfection of mammalian cells, we observed the
distribution of PSRPK fluorescent fusion protein in mammalian cells using confocal microscopy and
found that the protein was mainly accumulated in the nucleus; this indicated that the motif
contained a nuclear localization signal (NLS). Further investigation with truncated PSPRK peptides
showed that the NLS (318PKKGDKYDKTD328) was localized in the alkaline -loop of a helix-loop-
helix motif (HLHM) of the C-terminal conserved domain. If the 318PKKGDK322 sequence was
deleted from the loop or K320 was mutated to T320, the PSRPK fluorescent fusion protein could not
enter and accumulate in the nucleus.
Conclusion: This study demonstrated that the 318PKKGDKYDKTD328 peptides localized in the
C-terminal conserved domain of PSRPK with the -loop structure could play a crucial role in the
NLS function of PSRPK.
Background
Serine/arginine (SR) protein-specific kinases (SRPKs) rep-
resent a class of evolutionarily conserved kinases that spe-
cifically phosphorylate the arginine/serine-rich (RS)
domains of the SR splicing factor [1]. After the identifica-
tion of SRPK1–the first SRPK–by Gui et al. [2,3], other
SRPKs such as SRPK2 [4], mouse SRPK1 and SRPK2 [5],
yeast Dsk1 [6] and Sky1p [7], nematode SPK-1 [8],
Trypanosoma cruzi TcSRPK [9], and Arabidopsis thaliana
SRPK4 [10] have been subsequently identified. Some
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studies have shown that SRPKs are mainly localized in the
cytoplasm, with only a few present in the nucleus [[2,5],
and [11]]. The SRPKs that are localized in the cytoplasm
regulate the nuclear import of SR proteins via phosphor-
ylation [12], while those in the nucleus regulate the
nuclear localization of the SR splicing proteins via phos-
phorylation [13-15]. Ding et al. [11] have discovered that
the spacer sequences present between the conserved
domains of mammalian SRPKs have cytoplasmic anchor-
ing function. However, there has been no report on the
nuclear localization signal (NLS) of SRPKs.
Model organism Physarum polycephalum is mitochondria-
containing primitive eukaryotes. Its life cycle includes a
single-celled amoeba, plasmodium (the main life form),
and sporulation stages. The nuclei in the same plasmo-
dium proliferate by way of synchronization of mitosis. In
our previous study, we identified an SRPK containing 426
amino acids (aa) from P. polycephalum; this kinase was
termed PSRPK (GenBank accession No. DQ140379). Sim-
ilar to other SRPKs, PSRPK also has 2 conserved domains
and can phosphorylate human SR protein alternate splic-
ing factor/splicing factor 2 (ASF/SF2). However, it differs
from other SRPKs in that the divergent motif ( N) in its
N-terminus is rich in acidic amino acids; the spacer
sequence of PSRPK between two conserved domains is
shorter than that of other SRPKs. In this study, the distri-
bution of PSRPK fluorescent fusion protein in mamma-
lian cells was observed using laser scanning confocal
microscopy. Maximum fluorescence was detected in the
nucleus, suggesting the existence of an NLS in PSRPK.
When the distribution of truncated PSPRK peptides was
observed, a putative NLS was found in the C-terminal of
PSRPK based on its homology to the classic NLS. When
the sequence was deleted or when lysine 320 in the
sequence was substitute by threonine, the cytoplasmic
distribution of PSRPK was observed.
Methods
Construction of expression plasmids containing PSRPK 
and truncated PSPRK peptides
pMD18-psrpk had been constructed previously [16].
PSRPK fragments were obtained by polymerase chain
reaction (PCR), using pMD18-psrpk as the template and
PSRPK-specific primers (Table 1). The resulting PCR frag-
ments and the mammalian expression vectors pDsRed1-
N1 and pECFP-C1 (Clontech) were digested with EcoRI
and BamHI. The digested fragments were subjected to aga-
rose gel electrophoresis, recovered from the gel, purified,
and ligated using T4 DNA ligase; this resulted in the
expression plasmids pDsRed-psrpk and pECFP-psrpk.
We designed the following truncated PSRPK peptides (Fig-
ure 1): TP1 ( N deletion), TP2 (spacer sequence and CD2
deletions), TP3 ( N and CD1 deletions), TP4 ( N, CD1,
and spacer sequence deletions), TP5 (without the
318PKKGDKYDK326 and 329DHLALMIELLG339 sequences),
TP6 (containing 318PKKGDKYDK326  and
329DHLALMIELLG339 sequences), TP7~TP9 (all without
the  318PKKGDKYDKTD328  sequence; further, TP7,
329~426 aa; TP8, 197~317 aa combined with 329~426
aa; TP9, 1~317 aa combined with 329~426 aa). Recom-
binant plasmids were constructed using the primer pairs
(Table 1) and the pMD18-psrpk, pDsRed1-N1, and
pECFP-C1 vectors, resulting in pECFP-tp1~pECFP-tp4,
pDsRed-tp5, pDsRed-tp6, pDsRed-tp7, pDsRed-tp8, and
pDsRed-tp9.
Construction of expression plasmids containing mutant 
and default PSRPK peptides
In order to understand the effect of the loop motif on
nuclear localization, we designed default PSRPK, namely,
PSRPKd  (318PKKGDK323  deletion) and mutant PSRPK,
namely, PSRPKm (K320  T320 mutation). The DNA frag-
ments containing psrpkd or psrpkm up- and downstream
Table 1: Primers used for cloning psrpk and tps
DNA fragmants sense and anti-sense primers
psrpk 1~1278 F1:5'-CCGGAATTCTATGGAAAACATATTCAAGGAGAAGG-3'
R1: 5'-ACGCGTCGACAGAAATGGAGGCACATCAGCC-3'
tp1 84~1278 5'-CCGGAATTCTATGGATAGCGAAGATGAGGGAAC-3'/R1
tp2 1~588 F1/5'-ACGCGTCGACAGCACGTTTTCAGGTTTGAG-3'
tp3 589~1278 5'-CCGGAATTCTATGGACCATCTGTTACGACCAG-3'/R1
tp4 778~1278 5'-CCGGAATTCTATGAAAATCGCCGATCTAGGCAC-3'/R1
tp5 589~951 F2: 5'-CCGGAATTCATGGACCATCTGTTACGACCAGACAC-3'
R2: 5'-ACGCGTCGACTGGCAAAAAAGGAGATCTCCGGTGG-3'
tp6 589~1029 F2/5'-ACGCGTCGACTGGCGCGGCATTCTTCCTAGTAGCTC-3'
tp7 985~1278 F3: 5'-ACGCGTCGACGATGGATCACTTGGCTTTGATGATTG-3'
R3: 5'-ATGCGGATCCGCCAGAAATGGAGGCACATCAGCC-3'
tp8 589~951
985~1278
F2/R2
F3/R3
tp9 1~951
985~1278
F4: 5'-CCGGAATTCATGGAAAACATATTCAAGGAGAAG-3'/R2
F3/R3BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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were obtained using the primers listed in Table 2 and
pMD18-psrpk  as the template. The 2 overlapping PCR
products were mixed in a ratio of 1:1, followed by dena-
turing at 94°C for 3 min and annealing at 55°C for 3 min.
Since there were 18 complementary bases (underlined
parts of primers, Table 2) in the 2 PCR fragments, they
would be complementary to the cohesive ends during
annealing at 55°C. The DNA with 5' and 3' overhangs
could be extended by DNA polymerase (Hot Start Taq
Polymerase; Qiagen) to form a complete DNA fragment at
72°C. Primer pair F4/R3 were introduced in the PCR reac-
tion for the amplification of the psrpkd  and  psrpkm
sequences. The 2 PCR products, psrpkd and psrpkm, were
inserted into pDsRed1-N1, resulting in the recombinant
plasmids pDsRed-psrpkd and pDsRed-psrpkm, respectively.
Transfection of mammalian cells with lipofectamine
The abovementioned recombinant plasmids were used to
transform E. coli DH5a cells. The positive recombinant
products were grown in Luria-Bertani (LB) medium con-
taining 30 g/ml kanamycin. The plasmids were isolated
using the alkaline lysis method, dissolved in Tris-EDTA
(TE) buffer, and quantified using GeneQuant pro (Amer-
sham Bioscience, GE Healthcare). The purified plasmid
(A260/A280 > 1.8) was diluted to 16 g/ml in serum-free
RPMI-1640 medium (Gibco). Lipofectamine™ 2000 (Inv-
itrogen) was diluted in serum-free RPMI-1640 medium
(40 l/ml) and then mixed with an identical volume of
plasmid solution, resulting in lipid-DNA complexes.
HeLa and L929 cells (ATCC) were cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum
(FBS; Hyclone), 100 IU/ml penicillin, and 100 g/ml
Distribution of fluorescent fused PSRPK in mammalian cells Figure 1
Distribution of fluorescent fused PSRPK in mammalian cells. a and b: DAPI staining nuclear of cells HeLa and L929 
containing pECFP-psrpk were observed under a BX51 fluorescent microscope (Olympus, 400×); c and d: distribution of CFP-
PSRPK in cells HeLa and L929 were observed under a confocal microscope (TCS SP2, Leica).
Table 2: Primers used for cloning psrpkd and psrpkm
DNA fragmants Sense and anti-sense primers
psrpkd 1~951
969~1278
F4/5'-GCAAAAAAGGAGATCTCCGGTGGCC-3'
5'-GGAGATCTCCTTTTTTGCTATGATAAGACAGAT-3'/R1
psrpkm 959A  959C F4/5'-GCAAAAAAGGAGATCTCCGGTGGCC-3'
5'-GGAGATCTCCTTTTTTGCCCCAAAACAGGAG-3'/R3BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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streptomycin at 37°C in a 5% CO2 incubator. The cells
were harvested while they were in the logarithmic phase
and 1.5 ml culture (approximately 1 × 105 cells) was
seeded into a 35-mm plate with a coverslip and cultured
for 24 h. The medium was replaced with serum-free RPMI-
1640 medium, and the cells were cultured for 1 h to initi-
ate transfection. The cells were overlaid with 200 l lipid-
DNA complexes and cultured for 5 h. The medium was
replaced with 1.5 ml of 10% FBS medium, and the cells
were further cultured for 48 h.
Staining of cells with 4',6-diamidino-2-phenylindole (DAPI)
The HeLa cells were transfected with pECFP-psrpk, and
L929 cells were transfected with pECFP-psrpk, pDsRed-
psrpk, pDsRed-tp5~pDsRed-tp5, pDsRed-psrpkd  and
pDsRed-psrpkm as described above, respectively. The trans-
fected cells were incubated on a coverslip for 48 h, follow-
ing which DAPI staining (Bitian) was performed for 5
min. The cells were washed 3 times (each wash, 5 min)
with D-Hands solution to remove DAPI. Fluorescence was
visualized under a fluorescence microscope (Olympus
BX51, 400×) or a confocal microscope (Leica TCS SP2,
1000×) at 465~495 nm (green) or 560~600 nm (red) in
order to observe the distribution of the fluorescent fusion
protein in the cells.
Three-Dimensional Structure Modeling of PSRPK
The three-dimensional (3-D) PSRPK structure was mod-
eled by the Swiss Institute of Bioinformatics program
SWISS-MODEL, available at http://swiss
model.expasy.org/, and the results analyzed by the Deep-
View program [17].
Results
PSRPK was mainly localized in the nucleus of mammalian 
cells
The DAPI-stained nucleus of cells HeLa and L929 trans-
fected with pECFP-psrpk were clearly observed under UV
excitation (Figure 2a, b). Confocal microscopy showed
that the distribution of cyan fluorescent protein (CFP)-
PSRPK was non-uniform and that this protein was
Schematic diagrams of truncated PSRPKs compared with PSRPK Figure 2
Schematic diagrams of truncated PSRPKs compared with PSRPK. TP1~TP7: Peptides containing the PSRPK aa 
29~426, 1~195, 196~426, 259~426, 197~317, 197~343, and 329~426, respectively; TP8: peptides containing 197~317 aa 
combined with 329~426 aa; TP9: peptides containing 1~317 aa combined with 329~426 aa. N: acidic divergent motif; 1~28 aa; 
CD1: conserved domain 1; 29~195 aa; CD2: conserved domain 2; 259~426 aa; spacer sequence: divergent motif between 
the 2 conserved domains; 196~258 aa. NLS: 318PKKGDKYDKTD328.BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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expressed mainly in the nucleus of the HeLa (Figure 2c)
and L929 (Figure 2d) cells.
Existence of an NLS on the C-terminal conserved domain 
of PSRPK
The expression and distribution of CFP fusion TP1, TP2,
TP3, and TP4 in mammalian cells were observed by con-
focal microscopy. Compare with the DAPI staining of the
nucleus (Figure 3a, b), the distribution of CFP-TP1 in
HeLa (Figure 3c) and L929 (Figure 3d) cells was similar to
that of CFP-PSRPK, i.e., both mainly accumulated in the
nucleus. This suggested that the deletion of  N had no
significant effect on the nuclear accumulation of PSRPK.
The distributions of CFP-TP3 and CFP-TP4 in HeLa (Fig-
Distribution of CFP-TPs in the mammalian cells HeLa and L929 observed under a confocal microscope (TCS SP2, Leica) Figure 3
Distribution of CFP-TPs in the mammalian cells HeLa and L929 observed under a confocal microscope (TCS 
SP2, Leica). The images a and b show DAPI staining nucleus of cells HeLa and L929; the images c and d, e and f, g and h, and 
i and j show CFP-TP1, CFP-TP2, CFP-TP3, and CFP-TP4 expressions in the HeLa and L929 cells, respectively.
Distribution of RFP-TP5~RFP-TP9 in L929 cells observed by a confocal microscope (TCS SP2, Leica) Figure 4
Distribution of RFP-TP5~RFP-TP9 in L929 cells observed by a confocal microscope (TCS SP2, Leica). Only RFP-
TP6, which contained 318PKKGDKYDKTD328, accumulated in the nucleus. a: Nucleus of a pDsRed-tp6-transfected L929 cells 
stained with DAPI and observed under a BX51 fluorescent microscope (Olympus, 400×), while TP8 and TP9 are peptides 
obtained by the deletion of 318PKKGDKYDKTD328from TP3 and PSRPK, respectively. b, c, d, e, and f: Expressions of RFP-
TP5~RFP-TP9 in L929 cells.BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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ure 3g, i) and L929 (Figure 3h, j) cells were similar to
those of CFP-PRPK and CFP-TP1, i.e., both mainly accu-
mulated in the nucleus. This indicated that PSRPK contin-
ued to accumulate in the nucleus despite the deletion of 
N, CD1, and the spacer sequence and that CD2 contains
an NLS peptide. Unlike the distributions of CFP-PSRPK,
CFP-TP1, CFP-TP3, and CFP-TP4, CFP-TP2 in HeLa (Fig-
ure 3e) and L929 (Figure 3f) cells exhibited diffuse distri-
bution. The results above indicated that the  N, CD1, and
spacer sequence deletions did not influence nuclear local-
ization of PSRPK and that an NLS was located in the C-ter-
minal conserved domain of PSRPK.
PSRPK NLS was located in the 318PKKGDKYDKTD328 
sequence
Confocal microscopy revealed that RFP-TP5 and RFP-TP7
were uniformly distributed in the L929 cells (Figure 4b,
d), indicating that there was no NLS in the TP5 and TP7
sequences. However, RFP-TP6 mainly accumulated in the
nucleus (Figure 4c), indicating that an NLS existed in TP6.
By comparing the amino acid sequences of TP5, TP6, and
TP7, we primarily confirmed that PSRPK NLS was located
in  318PKKGDKYDKTD328. RFP-TP8 and RFP-TP9 were
mainly distributed in the cytoplasm (Figure 4e, f); this fur-
ther indicated that PSRPK and TP3 lost the ability of
nuclear localization after the deletion of the abovemen-
tioned sequence. Thus, we could confirm that
318PKKGDKYDKTD328 was the NLS sequence of PSRPK.
The NLS sequence of PSRPK contained a -loop motif
Analysis of the secondary structure of
318PKKGDKYDKTD328  within PSRPK by DNASIS v2.5
Demo revealed that it was a -turn (Figure 5A). Based on
the crystal structure of SRPK1 and Sky1p [17], the tertiary
structure of PSRPK (Figure 5B) was predicted using
SWISS-MODEL software [18-20]. Figure 5B shows that the
A: Secondary structure of PSRPK NLS, as predicted by DNASIS v2.5 Demo Figure 5
A: Secondary structure of PSRPK NLS, as predicted by DNASIS v2.5 Demo. The capital H, S and T blow the 
sequence represent the corresponding amino acid above has more probability to form helix, sheet or turn. B: The overall 
structure of PSRPK that mimics the structures of SRPK1 and Sky1p, as predicted by SWISS-MODEL online and displayed by 
SWISS-Pdb viewer compared with the overall structure of SRPK1 and Sky1p [17-20]. C: NLS, the NLS of PSRPK; NLSd, the 
NLS of PSRPK without 318PKKGDK323; NLSm, the NLS of PSRPK with the K320  T320 mutation.BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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structure 318PKKGDKYDKTD328 mimics that of the corre-
sponding sequences of SRPK1 and Sky1p. All the 3
sequences are located in the C-terminal loop motif. The
spatially near K320 and D325 may form a salt-bridge via
their side chains, causing the 318PKKGDKYDKTD328 to
form a stable -loop. This structure of
318PKKGDKYDKTD328 changes after 318PKKGDK323 dele-
tion or K320  T 320 mutation, as predicted by SWISS-
MODEL software (Figure 5C). 318PKKGDK323  deletion
causes damage to the -loop motif, and K320  T320 muta-
tion damages the salt-bridge in the -loop.
The fluorescent fusion proteins PSRPKd and PSRPKm in
the L929 cells are shown in Figure 6. Compare with the
DAPI staining of the nuclear (Figure 6B1a, B2a), the fluo-
rescent signal of RFP-PSRPKd  and RFP-PSRPKm  was
observed in cytoplasm (Figure 6B1b, B2b). Further, con-
focal microcopy revealed that RFP-PSRPKd  and RFP-
PSRPKm were mainly distributed in the cytoplasm (Figure
6B1c, B2c); this indicated that the 318PKKGDK323 deletion
or K320  T320 mutation destroyed the structure of PSRPK
NLS, resulting in PSRPK losing its ability of nuclear local-
ization.
Discussion
PSRPK has an NLS sequence
Ding et al. [11] studied the cell localization of mamma-
lian SRPKs and found that almost all SRPKs without
spacer sequences are accumulated in the nucleus, indicat-
ing that there is a cytoplasm localization signal in the
spacer sequence between the conserved domains. Kuroy-
anagi et al. [5] speculated that mouse SRPK1 might have
2 potential NLSs that are located in 11~21 aa and
265~277 aa; thus, mSRPK2 may have a potential NLS in
264~276 aa. However, direct evidence of NLS sequences
in SRPK family members has been lacking thus far. Laser
scanning confocal microscopy revealed that RFPs of
default PSRPKs containing 318PKKGDKYDKTD328 mainly
accumulated in the nucleus of mammalian cells, while the
PSRPKs in which the abovementioned sequence was
deleted did not accumulate in the nucleus. This indicated
that the NLS of PSRPK was located in the
318PKKGDKYDKTD328 sequence of the C-terminal con-
served domain.
Further, Ding et al. [11] showed that mammalian SRPKs
were mainly distributed in the cytoplasm. However, the
A: Schematic diagrams of default PSRPK and mutant PSRPK compared with PSRPK Figure 6
A: Schematic diagrams of default PSRPK and mutant PSRPK compared with PSRPK. B: Distribution of RFP-
PSRPKd and RFP-PSRPKm expression in L929 cells. PSRPKd, default PSRPK without 318PKKGDK323; PSRPKm, mutant PSRPK 
with the K320  T320mutation. 1 and 2: Distribution of RFP-PSRPKd and RFP-PSRPKm expressions in L929 cells observed under 
a confocal microscope (TCS SP2, Leica) compared with their position in the nucleus in DAPI-stained cells observed under a 
BX51 fluorescent microscope (Olympus, 400×).BMC Biochemistry 2009, 10:22 http://www.biomedcentral.com/1471-2091/10/22
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results obtained in our study showed that PSRPK was
mainly expressed in the nucleus of the mammalian cells.
A comparison of the primary structure of PSRPK and other
SRPKs revealed that the conserved domains were almost
identical; however, the nonconserved  N and spacer
sequence differed among the kinases. A cytoplasm locali-
zation signal was present in the spacer sequences of mam-
malian SRPKs. Further, the spacer sequence of PSRPK was
considerably smaller than that of mammalian SRPKs. This
difference might be the major reason why PSRPK cannot
anchor itself in the mammalian cytoplasm.
Function of the PSRPK NLS is related to the loop motif
A classic NLS (cNLS) comprises a monopartite or bipartite
signal. A monopartite NLS contains 1 cluster of basic resi-
dues, while a bipartite NLS contains 2 clusters of basic res-
idues [21]. Similar to the sequence feature of a
monopartite NLS, the NLS of PSRPK is rich in basic resi-
dues. A monopartite NLS sequence that is located at the
terminal of a protein is usually in a coil, while that located
in the interior of a protein is usually in a loop. The PSRPK
NLS is also located in the basic loop between 2 -helixes
(Figure 5). The close side chains of K320 and D325 form a
salt bridge, thus forming a stable NLS -loop motif (Fig-
ure 5C). The experimental results showed that PSRPK lost
its nuclear localization ability following the deletion of 318
PKKGDK323 or mutation from K320 to T320. The deletion or
mutation destroyed the -loop motif of PSRPK, thus sug-
gesting that the loop structure of PSRPK NLS controls the
nuclear localization of PSRPK. The 318PKKGDKYDKTD328
sequence, which corresponds to the nonconserved
sequences of SRPK1 and Sky1p, is located in the loop of
an HLHM [18,19] (Figure 5B). Therefore, studies on NLSs
of SRPKs should focus on the loops in HLHMs.
Conclusion
In this study, by truncation of PSRPK protein, deletion of
and single amino acid substitution in a putative NLS and
transfection of mammalian cells, we demonstrated that
the 318PKKGDKYDKTD328 peptides localized in the C-ter-
minal conserved domain of PSRPK with the -loop struc-
ture could play a crucial role in the NLS function of
PSRPK.
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